Results: 4

1.
Figure 4

Figure 4. From: Enteric absorption and pharmacokinetics of oseltamivir in critically ill patients with pandemic (H1N1) influenza.

Scatterplot showing the relation between normalized creatinine clearance and the elimination rate of oseltamivir carboxylate. Solid line represents the linear regression fit across all patients.

Robert E. Ariano, et al. CMAJ. 2010 March 9;182(4):357-363.
2.
Figure 3

Figure 3. From: Enteric absorption and pharmacokinetics of oseltamivir in critically ill patients with pandemic (H1N1) influenza.

Scatterplot showing the relation between body weight and volume of distribution for oseltamivir carboxylate. Solid line represents the linear regression fit across all patients. F = systemic bioavailability.

Robert E. Ariano, et al. CMAJ. 2010 March 9;182(4):357-363.
3.
Figure 2

Figure 2. From: Enteric absorption and pharmacokinetics of oseltamivir in critically ill patients with pandemic (H1N1) influenza.

Average plasma concentrations of oseltamivir carboxylate over one dosing interval in five patients admitted to ICU with suspected or confirmed pandemic (H1N1) influenza who received continuous renal replacement therapy. Oseltamivir doses were normalized to 75 mg twice daily. The horizontal line in the middle of each box indicates the median, and the top and bottom borders of the box mark the 25th and 75th percentiles, respectively. The whiskers are 1.5 times the upper and lower interquar-tile ranges. The outlier (black dot) indicates a case with values between 1.5 and 3 box lengths from one side of the range.

Robert E. Ariano, et al. CMAJ. 2010 March 9;182(4):357-363.
4.
Figure 1

Figure 1. From: Enteric absorption and pharmacokinetics of oseltamivir in critically ill patients with pandemic (H1N1) influenza.

Average plasma concentrations of oseltamivir carboxylate over one dosing interval in 34 patients admitted to intensive care unit (ICU) with suspected or confirmed pandemic (H1N1) influenza who did not require dialysis (primary study cohort). Oseltamivir doses were normalized to 75 mg twice daily. The horizontal line in the middle of each box indicates the median, and the top and bottom borders of the box mark the 25th and 75th percentiles, respectively. The whiskers are 1.5 times the upper and lower interquartile ranges. The outlier (black dot) indicates a case with values between 1.5 and 3 box lengths from one side of the range. The extreme values (*) indicate cases with values more than 3 box lengths from the 75th or 25th percentile.

Robert E. Ariano, et al. CMAJ. 2010 March 9;182(4):357-363.

Supplemental Content

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Write to the Help Desk